Aerobic Walking Exercise for Non-Ambulatory Stroke Survivors
NCT ID: NCT03479632
Last Updated: 2019-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2018-03-05
2020-03-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Develop a Walking Exercise Program for Non-ambulatory Stroke Survivors
NCT06247553
Aerobic Exercise in Early Subacute Stroke
NCT02107768
Aerobic Exercise Training in Acute Ischaemic Stroke
NCT04742686
Attendance and Adherence to Aerobic Exercise After Stroke
NCT07007507
Exercise Training and Walking Ability After Chronic Stroke
NCT00107068
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
The intervention group will undergo an aerobic walking program using a treadmill, a body-weight support system, and an assistive device.
Aerobic walking program
Participants will make 24 visits over an 8 week period, having 3 sessions per week. Each session will last about one hour.
Control Group
The control group will receive standard physical therapy (PT).
Standard physical therapy
Participants will receive standard care they normally would after a stroke.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aerobic walking program
Participants will make 24 visits over an 8 week period, having 3 sessions per week. Each session will last about one hour.
Standard physical therapy
Participants will receive standard care they normally would after a stroke.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be able to understand and follow verbal commands in English
* Have physicians' approval for exercise, and be in stable medical condition
* Participant's first stroke
* Unable to walk independently according to Functional Ambulation Category (FAC) (\<2) after in-patient rehabilitation treatment
* Between 6 weeks to 5 years after stroke onset
Exclusion Criteria
* Musculoskeletal disorder which prevents subjects from participating in the exercise
* Resting blood pressure more than 200/110 mm Hg
* Current or previous pulmonary diseases in the past two years
* Osteoporosis and restricted passive movement in the major joints of the lower limbs
* Subjects will be excluded if they are unable to speak or understand English and/or unable to travel to the University of Kansas Medical Center (KUMC) Neuromuscular Research Laboratory
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Kansas Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wen Liu
Role: PRINCIPAL_INVESTIGATOR
University of Kansas Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Kansas Medical Center
Kansas City, Kansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00140799
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.